Endogenous central calcitonin (CT) receptor agonist that stimulates cAMP formation at a potency 350-fold greater than CT (ED50 values are 0.2 and 71 nM respectively). Displays no activity at calcitonin-gene related peptide (CGRP) and adrenomedullin receptors. Inhibits formation of multinuclear osteoclasts with similar efficacy to CT in vitro. Suppresses food intake and increases body temperature in free-feeding rats, and significantly decreases plasma calcium levels in vivo.

WAY-620057 是一种抑制剂，针对 RAD51 重组酶家族中的蛋白质-蛋白质相互作用。

BT173 是一种新型同源结构域相互作用蛋白激酶 2 (HIPK2) 抑制剂，通过抑制 TGF-?1/Smad3 途径减轻肾纤维化。